Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
meeting entities : Applied genetic technologies corporation save search
AGTC to Present Three-Month Interim Results from the SKYLINE Clinical Trial of AGTC-501 for the Treatment of X-Linked Retinitis Pigmentosa at the 45th Macula Society Annual Meeting
Published: 2022-06-06 (Crawled : 17:00) - biospace.com/
OTIC | $0.077
|
Health Technology
|
| O: 2.04%
H: 2.5%
C: -1.5%
AGTC | News | $0.3936 1.23% 0.0%
|
Health Technology
|
| O: 2.06%
H: 0.24%
C: -1.95%
agtc-501 treatment trial
Positive 18-Month Data from Ongoing Phase 1/2 Clinical Study of AGTC-501 Presented at the Association for Research in Vision and Ophthalmology 2022 Annual Meeting
Published: 2022-05-04 (Crawled : 17:00) - biospace.com/
OTIC | $0.077
|
Health Technology
|
| O: -0.8%
H: 0.0%
C: -1.2%
AGTC | News | $0.3936 1.23% 0.0%
|
Health Technology
|
| O: 0.48%
H: 1.8%
C: -4.96%
agtc-501 ongoing research positive phase 1
AGTC to Present at Cell & Gene Meeting on the Mediterranean
Published: 2022-04-14 (Crawled : 14:20) - biospace.com/
OTIC | $0.077
|
Health Technology
|
| O: -1.33%
H: 2.69%
C: 0.0%
AGTC | News | $0.3936 1.23% 0.0%
|
Health Technology
|
| O: 0.0%
H: 7.14%
C: 4.76%
AGTC to Showcase Interim Findings from Ongoing XLRP and Achromatopsia Phase 1/2 Trials at the Association for Research in Vision and Ophthalmology 2022 Annual Meeting
Published: 2022-04-04 (Crawled : 21:00) - globenewswire.com
OTIC | $0.077
|
Health Technology
|
| O: -0.41%
H: 0.41%
C: -1.24%
AGTC | News | $0.3936 1.23% 0.0%
|
Health Technology
|
| O: 0.0%
H: 3.67%
C: 0.0%
ongoing trials research phase 1
AGTC Presents Data from Ongoing Phase 1/2 Trial of AGTC-501 at Upcoming American Academy of Ophthalmology 2021 Annual Meeting
Published: 2021-11-12 (Crawled : 13:15) - globenewswire.com
OTIC | $0.077
|
Health Technology
|
| O: 2.38%
H: 0.0%
C: 0.0%
AGTC | News | $0.3936 1.23% 0.0%
|
Health Technology
|
| O: 1.21%
H: 0.0%
C: 0.0%
ongoing phase 1 trial
AGTC to Present at Upcoming Cell & Gene Management Meeting on the Mesa
Published: 2021-10-12 (Crawled : 18:00) - biospace.com/
OTIC | $0.077
|
Health Technology
|
| O: 0.0%
H: 3.45%
C: 0.0%
AGTC | News | $0.3936 1.23% 0.0%
|
Health Technology
|
| O: 0.38%
H: 5.56%
C: 4.98%
AGTC to Present at Upcoming Cell & Gene Meeting on the Mesa
Published: 2021-10-12 (Crawled : 15:15) - globenewswire.com
OTIC | $0.077
|
Health Technology
|
| O: 0.0%
H: 3.45%
C: 0.0%
AGTC | News | $0.3936 1.23% 0.0%
|
Health Technology
|
| O: 0.38%
H: 5.56%
C: 4.98%
AGTC to Present at American Optometric Association’s Optometry’s Meeting
Published: 2021-06-22 (Crawled : 12:00) - biospace.com/
OTIC | $0.077
|
Health Technology
|
| O: 1.35%
H: 1.77%
C: -3.54%
AGTC | News | $0.3936 1.23% 0.0%
|
Health Technology
|
| O: 0.48%
H: 0.65%
C: -0.72%
presentation
Otonomy and AGTC Present Preclinical Proof-of-Concept Results for OTO-825 Gene Therapy at ASGCT Annual Meeting
Published: 2021-05-14 (Crawled : 12:00) - globenewswire.com
OTIC | $0.077
|
Health Technology
|
| O: -0.48%
H: 7.66%
C: -0.96%
AGTC | News | $0.3936 1.23% 0.0%
|
Health Technology
|
| O: 2.45%
H: 3.72%
C: 3.19%
gene therapy therapy results gene therapies preclinical pre-clinical
AGTC Advances in AAV Gene Therapy Manufacturing to be Presented at the American Society of Gene & Cell Therapy 24th Annual Meeting
Published: 2021-05-04 (Crawled : 12:15) - globenewswire.com
AGTC | News | $0.3936 1.23% 0.0%
|
Health Technology
|
| O: -2.91%
H: 0.75%
C: -3.0%
gene therapy therapy aav9 gene therapies
AGTC Announces Data to be Presented from the Ongoing XLRP and Achromatopsia Clinical Trials at the ARVO 2021 Virtual Annual Meeting
Published: 2021-04-29 (Crawled : 12:00) - globenewswire.com
AGTC | News | $0.3936 1.23% 0.0%
|
Health Technology
|
| O: 3.12%
H: 1.86%
C: 0.0%
ongoing clinical trials trial
Otonomy and AGTC to Present Preclinical Proof-of-Concept Results for OTO-825 Gene Therapy at ASGCT Annual Meeting
Published: 2021-04-28 (Crawled : 12:00) - globenewswire.com
OTIC | $0.077
|
Health Technology
|
| O: 0.0%
H: 6.81%
C: 5.11%
AGTC | News | $0.3936 1.23% 0.0%
|
Health Technology
|
| O: 2.78%
H: 3.2%
C: 2.71%
gene therapy therapy results gene therapies preclinical pre-clinical
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.